Anila Qureshi
About Anila Qureshi
Anila Qureshi is the Senior Medical Director of Immuno-Oncology Clinical Development at Bristol-Myers Squibb, with over thirteen years of experience in clinical research and drug development.
Company
Anila Qureshi is currently employed at Bristol-Myers Squibb, where she holds the position of Senior Medical Director, Immuno-Oncology Clinical Development. Located in Lawrenceville, NJ, Bristol-Myers Squibb is known for its pharmaceutical research and development, particularly in the field of immuno-oncology.
Education and Expertise
Anila Qureshi has an extensive educational background in medicine and public health. She earned her Doctor of Medicine (M.D.) from Baqai Medical University, Karachi, from 1989 to 1995. She furthered her expertise by obtaining a Master of Public Health (MPH) from Boston University from 2000 to 2002. Her education laid the foundation for a robust career in clinical research and drug development.
Background
Anila Qureshi has over thirteen years of experience in the fields of clinical research, drug development, drug safety, medical affairs, and project management. Her extensive experience includes work on Phase Ib, II, III, and IV clinical trials across multiple geographies such as the USA, Canada, Australia/New Zealand, Europe, South America, and Asia.
Specialization in Oncology
Anila Qureshi specializes in oncology and immuno-oncology. She has experience in treating various malignancies, including hepatocellular, gastric, lung, breast, bladder, prostate, melanoma, and hematologic malignancies such as ALL, AML, CLL, CML, and lymphomas. Additionally, she has research experience in cardiovascular and pain therapeutic areas.
Role and Responsibilities
In her current role at Bristol-Myers Squibb, Anila Qureshi provides input and support for Life Cycle Management Plans and Medical Strategies. She interacts with Key Opinion Leaders (KOLs) for indication-specific advice and leads collaborations with KOLs or major institutions globally. Her responsibilities include medical oversight for multi-therapeutic projects, developing and leading external advisory panels, and managing direct and indirect reports, external partners, consultants, vendors, and budgets.
Clinical Trials and Medical Oversight
Anila Qureshi has developed expertise in protocol development and implementation for various forms and guidelines, including electronic and paper CRFs, informed consent forms, SAE report forms, patient diary cards, patient registration forms, the randomization process, monitoring guidelines, IWRS, and IVRS. She developed and implemented global and regional SOPs for clinical operations and clinical safety and pharmacovigilance. Her proficiency in ARGUS and experience with MedDRA and WHOart ensure compliance with US and international regulatory standards.